Investments
21Portfolio Exits
13
Want to inform investors similar to International Biomedicine Management Partners about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
International Biomedicine Management Partners Investments
21 Investments
International Biomedicine Management Partners has made 21 investments. Their latest investment was in Sunesis Pharmaceuticals as part of their PIPE - III on September 9, 2010.
International Biomedicine Management Partners Investments Activity
International Biomedicine Management Partners Portfolio Exits
13 Portfolio Exits
International Biomedicine Management Partners has 13 portfolio exits. Their latest portfolio exit was Enanta Pharmaceuticals on March 21, 2013.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
3/21/2013 | IPO | Public | 2 | ||
10/21/2010 | Acquired | 1 | |||
11/26/2008 | Acq - P2P | 1 | |||
Date | 3/21/2013 | 10/21/2010 | 11/26/2008 | ||
|---|---|---|---|---|---|
Exit | IPO | Acquired | Acq - P2P | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 2 | 1 | 1 |
International Biomedicine Management Partners Team
1 Team Member
International Biomedicine Management Partners has 1 team member, including current Founder, Stefan Ryser.
Name | Work History | Title | Status |
|---|---|---|---|
Stefan Ryser | A-Cube, Aridis Pharmaceuticals, Telik, Roche, and Biomedicine | Founder | Current |
Name | Stefan Ryser |
|---|---|
Work History | A-Cube, Aridis Pharmaceuticals, Telik, Roche, and Biomedicine |
Title | Founder |
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.